Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine

被引:3
|
作者
Schuler, Martin J. [1 ]
Becker, Dustin [1 ]
Mueller, Matteo [2 ]
Bautista Borrego, Lucia [2 ]
Mancina, Leandro [2 ]
Huwyler, Florian [3 ]
Binz, Jonas [1 ]
Hagedorn, Catherine [2 ]
Schaer, Beatrice [4 ]
Gygax, Erich [5 ]
Weisskopf, Miriam [6 ]
Sousa Da Silva, Richard Xavier [2 ]
Antunes Crisostomo, Joao Miguel [1 ]
Dutkowski, Philipp [2 ]
Rudolf von Rohr, Philipp [7 ]
Clavien, Pierre-Alain [2 ]
Tibbitt, Mark W. [3 ]
Eshmuminov, Dilmurodjon [2 ]
Hefti, Max [1 ]
机构
[1] Univ Zurich, Wyss Zurich ETH Zurich, CH-8092 Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Surg, Swiss Hepato Pancreato Biliary & Transplantat Ctr, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, Zurich, Switzerland
[4] Securecell AG, Entwicklung Biomed Anwendungen, Urdorf, Switzerland
[5] Fumed AG, Forsch & Entwicklung, Muri, Switzerland
[6] Univ Zurich, Univ Zurich Hosp, Surg Res Ctr, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Transport Proc & React Lab, Zurich, Switzerland
关键词
clearance; free hemoglobin; hemolysis; lactate; liver perfusion; long-term perfusion; perfusion parameters; subnormothermic; normothermic perfusion; CARDIOPULMONARY BYPASS; BLOOD; TRANSPLANTATION; PRESERVATION; METABOLISM; PULSATILE; MICROCIRCULATION; HEMOGLOBIN; DELIVERY; ORGAN;
D O I
10.1111/aor.14403
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week. Methods Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process. Results Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver). Conclusion Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [21] Assessment of Biliary Regeneration During Long Term (>5 Days) Ex-vivo Normothermic Machine Perfusion
    Ly, Mark
    Lau, Ngee-Soon
    Dennis, Claude
    Huang, Joanna L.
    Toomath, Shamus
    Cabanes-Creus, Marti
    McKenzie, Catriona
    Kench, James
    Majumdar, Avik
    Gorrell, Mark
    McCaughan, Geoffrey
    Crawford, Michael
    Pulitano, Carlo
    TRANSPLANTATION, 2022, 106 (09) : S236 - S236
  • [22] SMALL ANIMAL MODEL OF NORMOTHERMIC EX VIVO LIVER MACHINE PERFUSION FOR LIVER TRANSPLANTATION
    Gassner, J. M. G. V.
    Moosburner, S.
    Noesser, M.
    Strobl, F.
    Michelotto, J.
    Claussen, F.
    Wyrwal, D.
    Pratschke, J.
    Sauer, I. M.
    Raschzok, N.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 29 - 29
  • [23] Preliminary Observations of An Ex Vivo Normothermic Whole Blood Machine Perfusion in An Experimental Liver Transplant Porcine Model
    Yoshimoto, Syuhei
    Soyama, Akihiko
    Fukumoto, Masayuki
    Hara, Takanobu
    Hidaka, Masaaki
    Torai, Shinji
    Kasamatsu, Hiroo
    Ishikawa, Jun
    Ohara, Masayuki
    Kobayashi, Eiji
    Eguchi, Susumu
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 1005 - 1011
  • [24] Indocyanine green (ICG) clearance as marker liver function during ex vivo normothermic machine perfusion
    Schurink, I. J.
    Willemse, J.
    Luijmes, S. H.
    de Goeij, F. H.
    Groen, P. C.
    Kucukerbil, E. H.
    Pascale, M. M.
    Shi, S.
    Polak, W. G.
    van der Laan, L. J.
    de Jonge, J.
    TRANSPLANTATION, 2023, 107 (09) : 21 - 21
  • [25] VIABILITY TESTING DURING EX VIVO NORMOTHERMIC MACHINE PERFUSION OF THE PORCINE LIVER BY ANALYSIS OF MITOCHONDRIAL RESPIRATION
    Hofmann, Julia
    Meszaros, Andras T.
    Hautz, Theresa
    Bogensperger, Christina
    Unterweger, Jasmin
    Fodor, Margot
    Messner, Franka
    Gasteiger, Silvia
    Mathis, Simon
    Putzer, Gabriel
    Martini, Judith
    Ottl, Felix
    Cardini, Benno
    Weissenbacher, Annemarie
    Oberhuber, Rupert
    Ofner, Dietmar
    Troppmair, Jakob
    Schneeberger, Stefan
    Resch, Thomas
    TRANSPLANT INTERNATIONAL, 2021, 34 : 54 - 54
  • [26] Long-term ex-vivo normothermic machine perfusion allows the repeated assessment and salvage of unusable human grafts with cholangiopathy
    Ly, M.
    Lau, N. -S.
    Ewenson, K.
    Mestrovic, N.
    Wang, C.
    Chanda, S.
    Majumdar, A.
    Kench, J. G.
    Gorrell, M. D.
    McCaughan, G. W.
    Crawford, M.
    Pulitano, C.
    TRANSPLANTATION, 2022, 106 (8S) : 19 - 19
  • [27] Blood Is Not Required for Normothermic Ex Vivo Liver Perfusion
    Boehnert, M. U.
    Yeung, J. C.
    Knaak, J. -M.
    Bazerbachi, F.
    Selzner, N.
    Keshavjee, S.
    Levy, G. A.
    Grant, D. R.
    Selzner, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 226 - 226
  • [28] Ex-vivo normothermic liver perfusion: an update
    Vogel, Thomas
    Brockmann, Jens G.
    Friend, Peter J.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (02) : 167 - 172
  • [29] Performance of Aged Liver Grafts in a Rat Model of Normothermic Ex Vivo Liver Machine Perfusion
    Moosburner, S.
    Zimmer, M.
    Gassner, J. M.
    Roschke, N.
    Berndt, N.
    Michelotto, J.
    Hillebrandt, K. H.
    Pratschke, J.
    Sauer, I. M.
    Raschzok, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 754 - 754
  • [30] Normothermic Machine Perfusion (NMP) of the Liver as a Platform for Therapeutic Interventions during Ex-Vivo Liver Preservation: A Review
    Dengu, Fungai
    Abbas, Syed Hussain
    Ebeling, Georg
    Nasralla, David
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)